Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.37 -0.02 (-5.13%)
At close: Nov 10, 2026 · 4:00 PM EST

Tenaya Therapeutics (TNYA) Change in Receivables (2026)

Updated

Tenaya Therapeutics' Change in Receivables came in at $17,000 for Q3 2026.

Analysis

Tenaya Therapeutics (TNYA) Change in Receivables (2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Tenaya Therapeutics reported Change in Receivables of $388,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -188.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -312.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -52.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tenaya Therapeutics 84.33 Mn 17.53 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17,000.00
Jun 30, 2026 -10.26 Mn
Mar 31, 2026 10.63 Mn
API Access

Tenaya Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TNYA&period=max&api_key=YOUR_API_KEY